Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
4DMedical Ltd ( (AU:4DX) ) just unveiled an update.
4DMedical Ltd has applied for quotation on the ASX of 70,064 new ordinary fully paid shares issued on 17 December 2025 under its employee incentive scheme. The modest size of the issue suggests a routine equity-based remuneration event designed to reward or retain staff, with limited immediate impact on the company’s capital structure but signalling continued use of share-based incentives in its employee compensation strategy.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd, listed on the ASX under the code 4DX, operates in the medical technology sector, focusing on advanced imaging solutions for respiratory and pulmonary diagnostics. The company develops and commercialises technology aimed at improving the detection, analysis and management of lung function, serving healthcare providers and patients in markets where high-precision respiratory imaging is in demand.
Average Trading Volume: 5,147,203
Technical Sentiment Signal: Buy
Current Market Cap: A$1.55B
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.